Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

AOR vs IBB: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, AOR returned +7.8% to IBB's +37.5%, and AOR charges 0.15% to IBB's 0.44%.

askIQ about this page

askIQ about AOR and IBB

Net assets: $3.9bn on Oct 28, 2026 for iShares Core 60/40 Balanced Allocation ETF, and $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF.

At a glance
+7.8%
AOR total return, 1 year
+37.5%
IBB total return, 1 year
0.15%
AOR expense ratio
0.44%
IBB expense ratio

Pair scorecard

AOR costs 0.29 points a year less; their one-year returns differ by 29.7 points; IBB is 2.8 times larger.

AOR vs IBB: Differences, Returns & Fees
MeasureAORIBB
Return
Total return, 1 year+7.8%+37.5%
Benchmark
What it tracks60/40 Balanced AllocationBiotech
Cost and size
Expense ratio0.15%0.44%
Net assets, as of Oct 27, 2026$3.9bn$11.0bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
Top ten holdings, share of the fund99.9%50%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, AOR and IBB hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first AOR IBB
Only in one fund ↓
Only in AOR
ISHARES CORE S&P ETF TRUST 35.70%
ISHARES CORE UNIV USD BOND ETF 32.15%
ISHARES CORE MSCI INT DEVEL ETF 17.10%
ISHARES CORE MSCI EMERGING MARKETS 6.34%
iShares Core Intl Aggregate Bnd ET 5.81%
ISHARES CORE S&P MID-CAP ETF 1.89%
ISHARES CORE S&P SMALL-CAP ETF 0.92%
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Check overlap with more funds →

Side by side

AOR iShares Core 60/40 Balanced Allocation ETF IBB iShares Biotechnology ETF
Where it sits Allocation ETF Thematic ETF
What it is Tracks an index of 60/40 Balanced Allocation Biotech
Total return, 1 year +7.8% +37.5%
Its benchmark over the same days +13.4% (ACWI) not measured
Gap to its benchmark −5.6 pts vs ACWI not measured
Expense ratio 0.15% 0.44%
Already in the S&P 500 0.0% 40.2%
Holdings 7 245
Net assets, AOR as of Oct 28, 2026 and IBB as of Oct 27, 2026 $3.9bn $11.0bn

AOR and IBB on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

AOR and IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
AOR

AOR tracks an index of 60/40 Balanced Allocation. Over the year to Oct 28, 2026 it returned +7.8% with distributions reinvested, against +13.4% for its benchmark, the MSCI All Country World Index. The prospectus expense ratio is 0.15% a year. By its holdings published by its issuer for Oct 27, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 7 positions, with the top ten at 99.9%.

IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

Questions people ask

Are AOR and IBB in the same category?
AOR is an allocation ETF and IBB is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, AOR or IBB?
In the year to Oct 28, 2026, with distributions reinvested, AOR returned +7.8% and IBB +37.5%.
Which is cheaper, AOR or IBB?
AOR is cheaper, by 0.29 percentage points a year. That is about $29 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do AOR and IBB overlap with the S&P 500?
By their latest filed holdings, 0% of AOR and 40% of IBB by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, AOR against IBB, data as of Oct 28, 2026. https://etfiq.com/compare/any/aor-vs-ibb

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.